维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="Bennett GC"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Meta-analysis:targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease显示文摘	Doherty GA Bennett GC Cheifetz AS	2010	Aliment Pharmacol Ther2010，31，8：	1
2	The fas counterattack in vivo:apoptotic depletion of tumor 2 infiltrating lymphocytes associated with fas ligand expression by human esophageal carcinoma显示文摘	O CONNELL J O SULLIVAN GC	1997	J clin Invest1997，99，：	1
3	Expression of Fas ligand by human gastric adenocarcinoma:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O'Connel J O'Sullivan GC	1999	Gut1999，44，2：	1
4	Expression of Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O Connel J O Sullivan GC	1999	Gut1999，44，：	1
5	Fas ligand expression in primary colon adenocarcinomas:evidence that the Fas counter attack is a prevalent mechanism of immune evasion in human colon cancer显示文摘	O' Connell J Bennett MW O' Sullivan GC	1998	J Pathol1998，186，1：	1
6	The Fas counterattack: Cancer as a site of immune privilege 显示文摘	Bennett MW O' Sullivan GC	1999	Immunol Today1999，20，1：	1
7	Expressionof Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in smmach cancer显示文摘	Bennett Mw O'connell J O'sullivan GC	2000	Gut2000，46，5：	1
8	The Fas counterattack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma显示文摘	Bennett MW O' Connel J O' Sullivan GC	1998	J Immunol1998，160，：	1
9	Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege显示文摘	O′connell J Bennett MW O′sulivan GC	1999	Clin Diagn Lab Immunol1999，6，：	1
10	Expression of Fas ( CD95/APO21 ) ligand by human gastric adenocarcinomas:a potential mechanismof immune escape in stomach cancer 显示文摘	O' Connel J Bennett MW O' Sullivan GC	1999	Gut1999，44，：	1
11	Expression of Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O'Connell J O'Sullivan GC	1999	Gut1999，44，：	1
12	Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium:a potential mechanism of apoptotic epithelial turnover 显示文摘	O' Connell J O'Sullivan GC	1999	DisEsophagus1999，12，2：	1
13	The Fas counterattack:cancer as a site of immune privilege显示文摘	Bennett MW O′Sullivan GC	1999	Immunology Today1999，20，1：	1
14	The Fas counterattack in vivo:apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma显示文摘	Bennett MW O Connell J O Sullivan GC	1998	J Immunol1998，160，11：	1
15	The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma 显示文摘	Bennett MW O′connell J L′sullivan GC	1998	Immunotherapy1998，48，160：	1
16	Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer 显示文摘	Bennett MW OConnell J OSullivan GC	1999	Gut1999，44，3：	1
17	The Fas counterattack:cancer as a site of immune privilege显示文摘	O'Connell J Bennett MW O'Sullivan GC	1999	Immunology Today1999，20，1：	1
18	The Fas counterattack:a molecular mechanism of tumor immune privilege显示文摘	O'Connell J Bennett MW O'Sullivan GC	1997	Mol Med1997，3，5：	1
19	The Fas counterattack ;cancer as a site of immune privilege显示文摘	O'Connell J Bennett MW O' Sullivan GC	1999	Immunol Today1999，20，1：	1
20	The Fas counterattack in vivo: apoptotic depletion of tumor- infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma显示文摘	Bennett MW O'connell J O'sullivan GC	1998	J Immunol1998，160，11：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示